Vimarsana
Biggest News Aggregation in the World

Amol Soin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amol Soin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amol Soin Today - Breaking & Trending Today

Neuronoff Announces Safety and Functionality Success in First-in-Human Trial of Injectrode for Minimally Invasive Chronic Pain Relief (LIFE study) - Vimarsana News

Neuronoff Announces Safety and Functionality Success in First-in-Human Trial of Injectrode for Minimally Invasive Chronic Pain Relief (LIFE study)

/PRNewswire/ -- Neuronoff, Inc., a pioneering medical device company dedicated to developing minimally invasive neuromodulation solutions, announced a...

Soin Neuroscience — Pain Relief Through Technology, Not Opioids - Vimarsana News

Soin Neuroscience — Pain Relief Through Technology, Not Opioids

Soin Neuroscience are pioneering pain treatment methodologies that circumvent the reliance on opioids in the hope of achieving non-addictive pain relief solutions.

Source: forbes.com
10 Business Owners Who Are Disrupting Industries In 2023 - Vimarsana News

10 Business Owners Who Are Disrupting Industries In 2023

Disruption! It's the aspiration of every budding business owner as they prepare for a new venture and introduce their product to the world.

JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain - Vimarsana News

JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain

/PRNewswire/ -- JanOne (Nasdaq: JAN), the visionary biotech company dedicated to discovering non-addictive treatments for pain, as well as causes of pain, has...

JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain - Vimarsana News

JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain

The Broad Patent Coverage is a Major Milestone for the Commercial Success of Jan123 LAS VEGAS, Aug. 29, 2023 /PRNewswire/ -- JanOne , the visionary biotech company dedicated to discovering...